Cargando…
Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction
Coronary microvascular dysfunction (MVD) is a syndrome of abnormal regulation of vascular tone, particularly during increased metabolic demand. While there are several risk factors for MVD, some of which are similar to those for coronary artery disease (CAD), the cause of MVD is not understood. We h...
Autores principales: | Lindner, Jonathan R., Davidson, Brian P., Song, Zifeng, Maier, Claudia S., Minnier, Jessica, Stevens, Jan Frederick, Ferencik, Maros, Taqui, Sahar, Belcik, J. Todd, Moccetti, Federico, Layoun, Michael, Spellman, Paul, Turker, Mitchell S., Tavori, Hagai, Fazio, Sergio, Raber, Jacob, Bobe, Gerd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540191/ https://www.ncbi.nlm.nih.gov/pubmed/34677363 http://dx.doi.org/10.3390/metabo11100648 |
Ejemplares similares
-
Relationship Between Low‐Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab
por: Shapiro, Michael D., et al.
Publicado: (2019) -
Resting coronary flow drives the daily pattern in coronary flow reserve in patients with chest pain without obstructive epicardial stenosis
por: Thosar, Saurabh S., et al.
Publicado: (2023) -
New developments in atherosclerosis: clinical potential of PCSK9 inhibition
por: Giunzioni, Ilaria, et al.
Publicado: (2015) -
Vasoconstrictor Eicosanoids and Impaired Microvascular Function in Inactive and Insulin Resistant Primates
por: Chadderdon, Scott M., et al.
Publicado: (2016) -
Validation of a multiplexed and targeted lipidomics assay for accurate quantification of lipidomes
por: Zhang, Nanyan Rena, et al.
Publicado: (2022)